Literature DB >> 18252267

Vascular risk factors in South Asians.

Konstantinos Tziomalos1, Charitha N Weerasinghe, Dimitri P Mikhailidis, Alexander M Seifalian.   

Abstract

South Asians originate from the Indian sub-continent (India, Pakistan, Bangladesh, Sri Lanka and Nepal) and represent one fifth of the world's population. Several studies suggested that South Asians have an increased risk of developing coronary heart disease (CHD) when compared with European populations. We review the role of traditional and emerging risk factors in the increased CHD risk in South Asians. The high prevalence of insulin resistance and type 2 diabetes mellitus in South Asians may be a major cause for their elevated vascular risk. However, other established and emerging risk factors are also overrepresented in South Asians. Large-scale prospective studies could determine the relative contribution of established and emerging vascular risk factors in South Asians. There is an urgent need for trials in South Asians that will evaluate clinical outcomes following treatment of these risk factors.

Entities:  

Mesh:

Year:  2008        PMID: 18252267     DOI: 10.1016/j.ijcard.2007.11.059

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  13 in total

1.  The effect of prior walking on coronary heart disease risk markers in South Asian and European men.

Authors:  Saravana Pillai Arjunan; Kevin Deighton; Nicolette C Bishop; James King; Alvaro Reischak-Oliveira; Alice Rogan; Matthew Sedgwick; Alice E Thackray; David Webb; David J Stensel
Journal:  Eur J Appl Physiol       Date:  2015-10-05       Impact factor: 3.078

2.  Percutaneous coronary intervention in Asians--are there differences in clinical outcome?

Authors:  Angela S Koh; Lay W Khin; Lok M Choi; Ling L Sim; Terrance S Chua; Tian H Koh; Jack W Tan; Stanley Chia
Journal:  BMC Cardiovasc Disord       Date:  2011-05-23       Impact factor: 2.298

3.  Estimating prevalence of coronary heart disease for small areas using collateral indicators of morbidity.

Authors:  Peter Congdon
Journal:  Int J Environ Res Public Health       Date:  2010-01-18       Impact factor: 3.390

Review 4.  Cerebrovascular disease in South Asia - Part II: Risk factors and prevention.

Authors:  Deepti Vibha; Kameshwar Prasad
Journal:  JRSM Cardiovasc Dis       Date:  2012-11-30

5.  Prevalence of diabetes in New York City, 2002-2008: comparing foreign-born South Asians and other Asians with U.S.-born whites, blacks, and Hispanics.

Authors:  Leena S Gupta; Charles C Wu; Stephanie Young; Sharon E Perlman
Journal:  Diabetes Care       Date:  2011-06-29       Impact factor: 19.112

6.  Do South Asian women with PCOS have poorer health-related quality of life than Caucasian women with PCOS? A comparative cross-sectional study.

Authors:  Georgina L Jones; Manisha Palep-Singh; William L Ledger; Adam H Balen; Crispin Jenkinson; Michael J Campbell; Hany Lashen
Journal:  Health Qual Life Outcomes       Date:  2010-12-20       Impact factor: 3.186

7.  Are we getting to lipid targets in real life?

Authors:  Niki Katsiki; Dimitri P Mikhailidis; Vasilis G Athyros; Apostolos I Hatzitolios; Asterios Karagiannis; Maciej Banach
Journal:  Arch Med Sci       Date:  2010-10-26       Impact factor: 3.318

Review 8.  Cerebrovascular disease in South Asia - Part I: A burning problem.

Authors:  Kameshwar Prasad; Deepti Vibha
Journal:  JRSM Cardiovasc Dis       Date:  2012-10-31

9.  Outcomes following percutaneous coronary revascularization among South Asian and Chinese Canadians.

Authors:  Martha H Mackay; Robinder Singh; Robert H Boone; Julie E Park; Karin H Humphries
Journal:  BMC Cardiovasc Disord       Date:  2017-04-19       Impact factor: 2.298

10.  Cardiovascular events and mortality in people with and without type 2 diabetes: An observational study in a contemporary multi-ethnic population.

Authors:  Briana Coles; Francesco Zaccardi; Suping Ling; Melanie J Davies; Nilesh J Samani; Kamlesh Khunti
Journal:  J Diabetes Investig       Date:  2020-12-15       Impact factor: 4.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.